Acorn Capital Advisors as of Dec. 31, 2024
Portfolio Holdings for Acorn Capital Advisors
Acorn Capital Advisors holds 21 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology (CGON) | 17.0 | $33M | 1.1M | 28.68 | |
| Y Mabs Therapeutics | 11.8 | $22M | 2.9M | 7.83 | |
| Candel Therapeutics (CADL) | 8.8 | $17M | 1.9M | 8.68 | |
| Urogen Pharma (URGN) | 8.5 | $16M | 1.5M | 10.65 | |
| Puma Biotechnology (PBYI) | 6.3 | $12M | 2.5M | 4.90 | |
| Bicara Therapeutics (BCAX) | 5.9 | $11M | 643k | 17.42 | |
| Terns Pharmaceuticals (TERN) | 5.7 | $11M | 2.0M | 5.54 | |
| Onkure Therapeutics Class A Com (OKUR) | 5.4 | $10M | 1.4M | 7.12 | |
| Trevi Therapeutics (TRVI) | 4.3 | $8.2M | 2.0M | 4.12 | |
| Protara Therapeutics Com Stk (TARA) | 3.5 | $6.8M | 1.3M | 5.28 | |
| Cybin Com New (CYBN) | 3.4 | $6.5M | 734k | 8.82 | |
| Cardiff Oncology (CRDF) | 3.3 | $6.3M | 1.4M | 4.34 | |
| Verastem Com New (VSTM) | 2.9 | $5.4M | 780k | 6.98 | |
| X4 Pharmaceuticals | 2.8 | $5.4M | 7.3M | 0.73 | |
| Mural Oncology (MURA) | 2.2 | $4.1M | 1.3M | 3.22 | |
| Aadi Bioscience (WHWK) | 1.9 | $3.6M | 1.1M | 3.15 | |
| Optinose Com New | 1.5 | $2.8M | 423k | 6.68 | |
| Q32 Bio (QTTB) | 1.5 | $2.8M | 803k | 3.44 | |
| Acrivon Therapeutics Common Stock (ACRV) | 1.3 | $2.4M | 405k | 6.02 | |
| Bioatla (BCAB) | 1.3 | $2.4M | 4.0M | 0.59 | |
| Vyne Therapeutics (VYNE) | 0.8 | $1.5M | 457k | 3.35 |
